0001104659-15-013577.txt : 20150224 0001104659-15-013577.hdr.sgml : 20150224 20150224211416 ACCESSION NUMBER: 0001104659-15-013577 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150221 FILED AS OF DATE: 20150224 DATE AS OF CHANGE: 20150224 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Legault Pierre CENTRAL INDEX KEY: 0001391045 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 15645702 MAIL ADDRESS: STREET 1: P.O. BOX 1028 STREET 2: C/O STONE MANAGEMENT LLC CITY: BERWYNE STATE: PA ZIP: 19312 4 1 a4.xml 4 X0306 4 2015-02-21 1 0000890465 NPS PHARMACEUTICALS INC NPSP 0001391045 Legault Pierre P.O. BOX 1028 C/O STONE MANAGEMENT LLC BERWYNE PA 19312 1 0 0 0 Stock Options (right to buy) 27.29 2015-02-21 4 D 0 20257 D 2024-11-03 Common Stock 20257 0 D Restricted Stock Units 2015-02-21 4 D 0 3816 D Common Stock 3816 0 D On November 3, 2014, the stock options were granted with one fourth vesting on the first anniversary of date of grant and 6.25% vesting on each quarterly anniversary thereafter. In connection with the merger of Knight Newco 2, Inc. with and into NPS Pharmaceuticals, Inc. (the "Issuer") on February 21, 2015, each outstanding stock option, whether vested or unvested, was cancelled in exchange for a single lump sum cash payment in an amount equal to the product of (1) the number of shares of the Issuer's common stock subject to such stock option and (2) the execess, if any, of $46.00 over the exercise price per share of such stock option. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock. On February 12, 2015, the Restricted Stock Units were granted with one hundred percent vesting on the first anniversary of date of grant. In connection with the merger of Knight Newco 2, Inc. with and into the Issuer on February 21, 2015, each outstanding Restricted Stock Unit was cancelled in exchange for a lump sum cash payment in an amount equal to the product of (1) $46.00 and (2) the number of shares of common stock subject to such Restricted Stock Unit. /s/ Pierre Legault, by Jill Thompson as attorney-in-fact 2015-02-24